System and method for treating various neurological disorders using synchronized nerve activation
11684771 · 2023-06-27
Assignee
Inventors
- Tamir Ben-David (Tel-Aviv, IL)
- Nimrod Kadim (Modi'in, IL)
- Shmuel Glasberg (Herzliya, IL)
- Ra'anan Gefen (Re'ut, IL)
Cpc classification
A61B5/165
HUMAN NECESSITIES
A61H2230/065
HUMAN NECESSITIES
A61B5/02416
HUMAN NECESSITIES
A61N1/0456
HUMAN NECESSITIES
A61N1/36082
HUMAN NECESSITIES
A61N1/36067
HUMAN NECESSITIES
A61B5/4088
HUMAN NECESSITIES
A61B5/0205
HUMAN NECESSITIES
A61B5/0245
HUMAN NECESSITIES
A61N1/36096
HUMAN NECESSITIES
A61B5/4082
HUMAN NECESSITIES
A61B5/4836
HUMAN NECESSITIES
A61B5/002
HUMAN NECESSITIES
A61H2230/045
HUMAN NECESSITIES
International classification
A61B5/00
HUMAN NECESSITIES
A61B5/0205
HUMAN NECESSITIES
A61N1/05
HUMAN NECESSITIES
Abstract
A neuromodulation system for treatment of physiological disorders. The system includes one or more stimulators for stimulating one or more cranial nerves; one or more detectors configured for detecting a predetermined physiological state; and a control unit that controls nerve stimulation by the one or more stimulators so that it is synchronized with the at least one predetermined physiological state detected by the one or more detectors. A method of neuromodulating a patient for treatment of physiological disorder. The method includes the steps of detecting a predetermined physiological state and applying stimulation to one of the cranial nerves during the predetermined physiological state by one or more stimulators of a neuromodulation system.
Claims
1. A neuromodulation system for treatment of physiological disorders comprising: at least one non-invasive cranial nerve stimulator comprising at least two electrodes for stimulating a vagus nerve, wherein at least one electrode of said at least two electrodes is configured to be attached to a concha of an ear, and at least one additional electrode of said at least two electrodes is configured to be attached to a back of the ear; and a control unit that controls stimulation by the at least one non-invasive cranial nerve stimulator via said at least two electrodes.
2. The system according to claim 1, further comprising at least one detector configured for detecting a predetermined physiological state.
3. The system according to claim 2, wherein the physiological state is selected from the group consisting of: sleep stage, cognitive emotional reaction, and change in body parameters.
4. The system of claim 3, wherein the cognitive emotional reaction is sadness, happiness, excitement or fear.
5. The system of claim 3, wherein the change in body parameters occurs in heart rate, slow or rapid eye movements, or brain waves.
6. The system according to claim 1, wherein the at least one non-invasive cranial nerve stimulator is configured to provide stimulation so as to provide treatment of physiological disorders, and neurological disorders selected from the group: Alzheimer's disease, sleep disorders, and heart pathologies.
7. The system according to claim 1, wherein the vagus nerve is the auricular branch of the vagus nerve.
8. The system according to claim 1, wherein the control unit is configured to provide a feedback mechanism that controls the at least one non-invasive cranial nerve stimulator, and wherein the feedback mechanism is feedback based on a cognitive result.
9. The system according to claim 2, wherein the detector is selected from electroencephalogram (EEG), eye tracking, electrocardiogram (ECG) or breathing monitoring.
10. The system according to claim 9, wherein the system includes a wired connection between the at least one detector, the control unit, a power supply and at the least one non-invasive cranial nerve stimulator.
11. The system according claim 10, wherein the system includes a wireless connection to a remote control unit.
12. The system according to claim 11, wherein the at least one non-invasive cranial nerve stimulator stimulates said vagus nerve in at least two stimulation sites.
13. The system according to claim 1, comprising at least one physiological state detector configured to detect at least one sleep stage, and wherein said control, unit is configured to initiate stimulation of said at least one vagus nerve when said at least one sleep stage is detected.
14. The system according to claim 1, wherein said system is a system for treatment of Alzheimer's Disease (AD) and/or dementia, and wherein the at least one non-invasive cranial nerve stimulator is configured to provide stimulation so as to provide treatment of said AD and/or of said dementia.
15. The system according to claim 1, comprising: at least one cognitive stimulator module for cognitive stimulation, and wherein said control unit controls the stimulation by the at least one non-invasive cranial nerve stimulator so that it is synchronized with the at least one cognitive stimulator module.
16. A method of neuromodulating treatment for Alzheimer's Disease (AD) or dementia in a patient, the method comprising: applying stimulation to a cranial nerve by at least one electrode of a cranial nerve stimulator of a neuromodulation system attached to a concha of an ear, thereby treating the AD or the dementia, wherein said applying comprises applying said stimulation to said cranial nerve by said at least one electrode attached to said concha of the ear and by at least one second electrode attached to a back of the ear.
17. A method of neuromodulating treatment for Alzheimer's Disease (AD) or dementia in a patient, the method comprising: applying stimulation to a cranial nerve by at least one electrode of a cranial nerve stimulator of a neuromodulation system attached to a concha of an ear, thereby treating the AD or the dementia, wherein said applying comprises applying said stimulation to said cranial nerve while said patient is asleep.
18. A method of neuromodulating treatment for Alzheimer's Disease (AD) or dementia in a patient, the method comprising: detecting that said patient is asleep; applying based on said detecting, stimulation to a cranial nerve by at least one electrode of a cranial nerve stimulator of a neuromodulation system attached to a concha of an ear, thereby treating the AD or the dementia, wherein said applying comprises applying said stimulation to said cranial nerve while said patient is asleep.
Description
LIST OF FIGURES
(1) The disclosed inventions will be described with reference to the accompanying drawings, which show important sample embodiments of the invention and which are incorporated in the specification hereof by reference, wherein:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
DETAILED DESCRIPTION OF THE INVENTION
(22) The present invention introduces an effective way to deliver one or more neurological activations for the treatment of neurological disorders. Nerve activators using different activation techniques may be controlled by a single control unit.
(23) Activators that may be used can provide at least one of the following types of stimulation: Electrical stimulation may be provided by a wide spectrum of activators, including sensory nerve activators and/or muscle activators. A specific example for this invention is stimulation of the vagus nerve. In a specific embodiment, such activation is done in an afferent direction, resulting in activation of brain centers that are linked to the vagus nerve. The stimulation can be effected by using an implanted nerve stimulator and a stimulation lead. Electrical nerve stimulation can also be effected by stimulation of nerves using a non-invasive external electrical stimulator. Electrical stimulation of muscle can be effected by activation of limb muscles at a predetermined frequency and intensity. (See
(24) The control unit of the system can include several communication links to interact with the one or more activators. Specific examples can be magnetic activation of an implantable nerve stimulator and remote activation of a computer-based cognitive stimulator. Another example of specific activation can be simultaneous activation of two or more separate implantable devices. These may be similar devices or different devices.
(25) Additionally, in some embodiments, the control unit can be configured to include power source to power the various activators wirelessly. A specific example of wireless powering can be using inductive coupling as an implantable nerve stimulator.
(26) The control unit can be designed to be an external, portable, easy to carry device that can be attached to the patient's body using a wearable element. (See
(27) Another embodiment of the control unit can include two separate parts: one part that is wearable and contains all the communication links and a second part that implements the user interface and the algorithms for optimization methods.
(28) The control unit can use several control algorithms to enhance or optimize the stimulation effectiveness as described in
(29) An external or internal sleep sensor provides input on the sleep stages. The sleep sensor unit can include several communication links to interact with an activator. A specific example can be a magnetic activator for providing magnetic activation of an implantable nerve stimulator. Another specific activation can be using Bluetooth signaling to a non-invasive tVNS ABVN stimulator.
(30) A specific example of a sleep sensor is an ‘under the mattress’ sleep sensor, using an electro-mechanical sensor, such as a piezo-electric sensor. (See
(31) The tVNS electrodes can be attached to the concha, to the ear canal surface, or have its electrodes split between the concha/external auditory canal, and the back of the ear, or both electrodes at the back of the ear. (See
(32) It is to be understood that the embodiments of the electrode herein described are merely illustrative of the application of the principles of the invention. It will be appreciated that many variations, modifications, among them ones based on ergonomic considerations, to allow comfortable use of the device during sleep, may be made. The ear Bluetooth unit can have its antenna on a chip, or to be printed or embedded in soft encapsulation.
(33) The stimulation electrode attached to skin near the ABVN can provide surface current pulses through monopolar electrodes, in the form of surface current, or through the ear tissue, where one monopolar electrode is located at the back of the ear at one of ABVN locations, and the other monopolar electrode is at the concha, or in the external auditory canal.
(34) In some configurations, stimulation can be applied through both locations simultaneously using several monopolar electrodes placed in the concha, in the external auditory canal or in other places inside the ear canal, using a reference electrode placed at the back of the ear.
(35) A sleep sensor may be of an eye mask type, a movement sensor or an electrical signal sensor that can be integrated into the ear stimulator. The sleep sensor may be connected to the ear stimulator via wires or via wireless communication, such as via a Bluetooth connection. (See
(36) The sleep sensor can use EEG signals measured from the head using dedicated electrodes. The EEG electrodes can be used for detecting sleep stages and changes in hippocampus activity, for example by monitoring theta waves.
(37) The device may have all its elements: power source, sleep sensor, control unit, stimulator in a single unit, or have all elements in one unit except for one of the following: the sleep sensor, the control unit, or the stimulation electrodes.
(38) In some cases, the stimulator can be placed simultaneously in both ears. (See
(39) Optimization can mean in one embodiment (see
(40) Cognitive stimulation using tVNS excitation (see
(41) In a specific embodiment such activation may include a questionnaire that the subject should answer. Another embodiment may include showing an emotion inducing picture that can trigger an emotional state in the subject. The cognitive activation can use tools such as an interactive tablet computer with a dedicated application that generates cognitive stimulation and collects responses from the patient. (See
(42) Sensory stimulation such as music can be added simultaneously with tVNS activation or other cranial nerve stimulation. Such activation can be initiated during specific sleep stages. In a specific embodiment, such audio activation may be by playing music that is familiar to the subject.
(43) Additionally, in some embodiments, the control unit can include a power source for powering the stimulator to which it is in wireless connection. A specific example can be powering the activator wirelessly by using inductive coupling.
(44) The tVNS stimulation or other cranial nerve stimulation may be used for improving the quality of sleep. Specifically, this can be affected by inducing additional periods of REM sleep or by prolonging the REM sleep periods when they occur.
(45) Sensory stimulation such as music or smell can be added simultaneously using tVNS activation while the user is awake.
(46) The control unit can use one or more of the following optimization methods to adjust the stimulation's timing/synchronization, intensity and patterns. (See
(47) The tVNS stimulation unit can be made of soft materials which enables it to be inserted into an ear with minimal effect on the subject's sleep. The tVNS stimulation unit can be a type of device located behind the ear (BTE), in the ear (ITE), in ear canal (IEC), or completely in ear canal (CIC), as in
(48) The CIC type device can be made of three units (see
(49) The ear unit has a means to adjust the properties of the stimulation waveform, such as the amplitude of the pulses, via programming of the control unit. The control unit can be accessed for parameter setting, with no contact to stimulator's circuitry or using a port for programming or having embedded potentiometers with access to adjusting tool such as screwdriver.
(50) Control of activation parameters can be affected using remote control from an external device. The activation parameters, such as electrical current pulse amplitude, can be re-adjusted based on the patient's feedback and also by using a cognitive test to evaluate the cognition potency. Alternatively, it can be readjusted based on the sleep parameters such as the duration of the REM sleep stage.
(51) An embodiment of the proposed system is comprised of electrical activation by the tVNS platform using a non-invasive stimulator and a sensor under or in a sleep mattress, with a Bluetooth communication link incorporated into both, as shown in
(52) All device types, including BTE, ITE as seen in
(53) The stimulation electrodes can be made of metal contacts shaped to optimally provide the electrical or heat pulses. They can be made of, or coated with, conductive adhesive material or conductive fabric.
(54) There can be electrodes placed in both ears (see
(55) The simulation can be applied in conjunction with or in relation to drug administration, in such way that the stimulation is synchronized with drug intake, or during the time when it is active. Nerve stimulation can enhance or suppress release of chemicals by the brain, such as neurotransmitters, in a timely manner with regard to drug activity.
(56) An embodiment of this invention includes a neuromodulation platform for treatment of neurological disorders comprising: a sensor measuring the parameters of specific body action; at least one nerve activator; and a control unit synchronizing the nerve activator to the body actions.
(57) The nerve activator can be one of the following stimulators: Electrical stimulator Mechanical stimulator Thermal stimulator Visual stimulator Audio stimulator Cognitive stimulator
(58) In a specific embodiment, the neuromodulation includes at least three activators.
(59) In some embodiments, the electrical stimulation is stimulation of the vagus nerve using an implantable stimulator.
(60) In some embodiments, the control unit of the stimulator includes a non-implantable magnetic wand that communicates with the implantable vagus nerve stimulator.
(61) The apparatus described above may also include a second stimulator that provides cognitive stimulation. The cognitive stimulator described above may also comprise a computerized viewer that is controlled by the control unit.
(62) In some embodiments, the nerve activator can be implemented in one of the following platforms: A completely implantable device A device including an external control unit and an implantable activator A device that is in direct contact with the treated subject's skin A device with a control unit that is not in contact with the subject being treated and an activator that is in direct contact with the treated subject skin A device that is totally not in direct contact with the treated subject
In some embodiments, the control unit for treatment of neurological disorders includes: A processing unit; and At least one communication module, each module in communication with a separate nerve activator.
The communication modules described above may perform communication through one of the following techniques: Magnetic field transmission Electrical field transmission Optical transmission Wireless transmission Wire electrical transmission Electrical stimulation Mechanical stimulation Thermal stimulation Visual stimulation Audio stimulation Cognitive stimulation
(63) The control unit described above may include a cognitive sensor for sensing cognitive markers or physiological signals.
(64) The control unit described above may include an adaptive control mechanism that can change the parameters of the activator based on an input from the cognitive sensor.
(65) The control unit described above may include an eye tracking sensor that detects the onset of rapid eye movement periods during sleep.
(66) The control unit described above may include a cognitive sensor that detects the intensity of cognitive activity and synchronizes the activator to apply stimulation during a period of high cognitive activity.
(67) In some embodiments, the processor that is connected to a control unit that is used for treatment of neurological disorders includes a data recording means that records at least one of the following inputs: The parameters of the activator The cognitive intensity as measured by EEG sensors or cognitive questionnaire Physiological signals such as heart rate, onset and termination of REM sleep periods, EEG, activity sensor, body temperature and bio-impedance
(68) The processor of the control unit described above may include an analyzer to perform multi-parameter analysis of the patient condition during treatment and during time between treatments.
(69) The current invention also relates to a neuromodulation platform for treatment of neurological disorders comprising: at least two parallel brain activators as shown in
(70) In some embodiments, the brain activation processes involves one of the following types of cognitive stimulations: audio, cognitive challenge, such as reading, solving puzzles, logic tasks and emotional challenge, such as experiencing happiness, fear or an excitement.
(71) In some embodiments, the neuromodulation platform comprises a vagus nerve stimulator and a detector for detecting sleep stages.
(72) In some embodiments, the neuromodulation platform is configured to detect REM sleep and provide stimulation only during REM sleep periods.
(73) In some embodiments the neuromodulation platform includes an ear stimulation platform to stimulate the auricular branch of the vagus nerve (ABVN).
(74) In some embodiments, the neuromodulation platform is configured to affect concentrations of bio-chemicals in the brain, such as proteins and neurotransmitters.
(75) In some embodiments, the neuromodulation platform is configured to provide stimulation that is synchronized with sleep stages and to treat physiological disorders such as Alzheimer's, sleep disorders, neurological disorders and heart pathologies such as heart failure and atrial fibrillation.
(76) In some embodiments, the ear stimulation platform comprising a non-invasive nerve activator includes one of the following configurations: an activator located behind the ear (BTE); an activator located in the ear (ITE); an activator located in the ear canal (IEC); and an activator located completely in the ear canal (CIC).
(77) In some embodiments, the ear stimulator comprises at least one set of radial anode and cathode electrodes placed at the ear canal.
(78) In some embodiments, the ear stimulation platform comprises an ear canal part with a middle core that enables sound transmission.
(79) In some embodiments, the middle core can be an open void.
(80) In some embodiments, the ear stimulator comprises an internal structure and encapsulation that allows it to conform to, or be adjustable with, the ear anatomy.
(81) In some embodiments, the ear stimulator includes a sound generator.
(82) In some embodiments, the neuromodulation platform includes two ear stimulators, one placed in the right ear and one in the left ear (See
(83) In some embodiments, the neuromodulation platform comprising two ear stimulators one for each ear, that have a connecting wire. In some embodiments, the neuromodulation platform comprises a feedback mechanism that controls the stimulation.
(84) In some embodiments, the feedback mechanism is selected from one of the following mechanisms: feedback mechanism based on heart rate; feedback mechanism based on EEG parameters measured by EEG electrodes; and feedback mechanism based on cognitive test results.
(85) In some embodiments, the neuromodulation platform comprises an electrical signal sensor and an ear stimulator.
(86) In some embodiments, the neuromodulation platform comprises a stimulator for stimulating the auricular branch of the vagus nerve and further comprising at least one anode and at least one cathode electrode that are in direct contact with the skin of an ear of the subject.
(87) In some embodiments the neuromodulation platform comprising at least one electrode placed in one of the following locations selected from the group of locations consisting of: the back of the ear, the concha and the ear canal.
(88) In some embodiments the neuromodulation platform comprises a sleep sensor in electrical communication with a processing unit and a communication module. The sleep sensor may detect at least one of the following parameters: onset of rapid eye movement during sleep, EEG signal, body activity, and heart rate.
(89) In some embodiments, the neuromodulation platform may have a control unit that adjusts the amplitude of the stimulation pulses, using an adjustable potentiometer.
(90) In some embodiments, the neuromodulation platform is a platform for promoting drug administration having a stimulator for stimulating the auricular branch of the vagus nerve. The platform comprising: an ear canal stimulation electrode of the stimulator; a drug delivery system for delivering a drug; and a control unit for synchronizing nerve stimulation with the timing of drug administration.
(91) In some embodiments, the drug delivery system is adapted for delivering insulin.
(92) In some embodiments, the drug delivery system is adapted for delivering drugs that are targeting the central nervous system.
(93) In some embodiments, the drug delivery system is adapted for delivering drugs for treatment of cardiac pathologies.
(94) In some embodiments, the drug delivery system is adapted for delivering drugs for treatment of cancer.
(95) In an embodiment, a neuromodulation platform for treating ADD or ADHD, the platform comprises:
(96) an EEG detector for measuring an EEG signal;
(97) a control unit establishing ADHD functional status using an analysis of the EEG signal;
(98) a stimulator for stimulation of the auricular branch of the vagus nerve of the subject; and
(99) a control unit that adjusts the stimulation parameters of the stimulator based on the established ADHD functional status.
(100) In an embodiment, a neuromodulation platform for treating depression, the platform comprising:
(101) an EEG detector for measuring an EEG signal;
(102) a detector for determining a depression status using EEG signal analysis;
(103) a stimulator of the auricular branch of the vagus nerve of the subject; and
(104) a control unit that adjusts the stimulation parameters for the stimulator based on the determined depression status.
(105) It should be noted that there is a standard depression status ladder and depression level is assessed accordingly.
(106) In an embodiment, a neuromodulation platform for treating migraines, the platform comprising:
(107) an EEG detector for measuring an EEG signal;
(108) a controller for determining a migraine status using an analysis of the EEG signal;
(109) a stimulator for stimulation of the auricular branch of the vagus nerve of the subject;
(110) and;
(111) a control unit that adjusts the stimulation parameters of the stimulator based on the detected migraine status.
(112) Electrical stimulators when electrical stimulation is used may be selected from among the following: Current control stimulator Voltage control stimulator Charge control stimulator Monophasic stimulator Dual phase stimulator Multiphase stimulator Single polarity stimulator Dual polarity stimulator
The above list is not intended to be an exhaustive list.
(113) The stimulators or detectors listed above may use different electrodes to deliver the stimulation or sense physiological parameters like EEG or ECG, such as: Capacitance electrode (nonconductive) for optimal biological interface assuring no electrons pass to the biological ion-charge system Conductive electrode enabling delivery of larger charges in specific time intervals Hybrid electrode, mostly capacitance with a residual of conduction, may be used as a compromise between the two prior types Mono-polar electrode can be used for better charge delivery, that is maximum usage of electrode area to deliver the same polarity Bi-polar electrode to enable better stimulation localization Reference electrode serving as grounding for most stimulation devices Dual-use electrode, for both sensing and stimulation. This requires high capacitance and high isolation between the sensing and stimulation functions Implantable nerve electrode will be warping the target nerve to increase the contact area and ensure good contact for long time periods. Wet electrode refers to an electrode with conductive hydrogel placed on top of it to improve conduction (decrease the resistance) between the electrode and the subject's skin or other organ. Dry electrode refers to an electrode that has a good skin interface and doesn't require a conductive hydrogel.
It should be apparent to persons skilled in the art that the stimulator electrodes used may be different from the sensing electrode used by detectors, also sometimes denoted herein as sensors, like EEG or ECG.
(114) Detectors usable in the systems described herein may include the following: EEG sensors containing at least two electrodes up to as many as 16 electrodes. These sensing electrodes can be dry or wet type electrodes. ECG sensor or heart rate sensor to sense heart rate and other heart events like tachycardia or other heart conditions. This sensor may be implemented by a photoplethysmography (PPG) sensor, or surface ECG sensor or implantable ECG sensor. Sleep sensor to monitor and differentiate sleep stages like REM or SWS. Sleep sensor may include ‘under the mattress sensor’, wearable sensor like watch type or remote sensor like desktop sensor. The sleep sensor may be based on technology like electro-mechanical sensor, such as a piezo-electric sensor, or a micro electro-mechanical system (MEMS) accelerometer. Motion sensor or actimetry sensor to monitor the activity intensity of the patient, like laying, seating, standing, walking etc. Breathing sensor to monitor the subject's breathing function. Eye tracking sensor may be used to distinguish sleep conditions like REM sleep or awake conditions like reading
(115) Cognitive stimulators may include: computer base stimulator like tablet, desktop, television, or smartphone. These devices may or may not interact with the patient. They may stimulate visual, audio and other senses in two dimension or three. These devices may implement virtual reality or augmented reality to stimulate the patient. Cognitive stimulation may require the patient to preform one or more of the following activities: reading, watching, answering a questionnaire, listening, orientating in 2-dimensional or 3-dimensional space. Specific stimulation can focus on different brain activities like mathematical problems, memory challenges, verbal tasks, visual tests, gross motoric functions or fine motoric functions, and more.
(116) Mechanical stimulators apply local pressure in different frequencies. Low frequency (up to 2 Hz) will feel like a pressure wave to the patient, and medium frequency (2 to 30 Hz) will feel more like vibrations. High frequencies (more than 30 Hz) are hard to feel directly but still may have nerve stimulation effects. The mechanical stimulator will require a mediator, like muscle, limb, or artery to stimulate an adjacent nerve and evoke a brain response. For example, massage (low frequency pressure wave) of the carotid artery is known to affect the carotid branch of the vagus nerve and induce unconscious.
(117) Thermal stimulators apply local heat or cold at specific spots on the body or to a whole organ. The stimulation effect, mediated by biological tissue like skin or tooth, to the nervous system conveys the sensed heat or cold to the brain. Thermal stimulation like feeling cold may heighten the patient's sensing, improving other stimulation effects, for example cognitive or electrical effects when the two stimulations are applied in time synchronization.
(118) Audio stimulators carry sound to a patient's ear through the air or by direct bone conduction. Audio stimulation is known to induce mode changes in a patient which in turn may enhance a patient's sensitivity to cognitive or electrical stimulation.
(119) A therapeutic method is describe herein intended to treat a physiological disorder from the list of: Alzheimer's Parkinson's, tremor, depression, migraine, headaches, peripheral pain, attention deficit disorder (ADD), attention deficit and hyperactivity disorder (ADHD), sleeping disorders, cognitive dysfunctions, arterial defibrillation and sexual dysfunctions.
(120) The method consists of stimulating cranial nerves, often, but without intending to limit the invention, the vagus nerve at specific physiological states to elicit a best therapeutic effect. Some physiological states comprise relevant events for therapy in each of the above disorders, for example, elevated cognitive state enhances vagus nerve stimulation (VNS) effect on cognition. Accordingly, by detecting the specific elevated cognitive states and applying VNS at this specific time, cognition rehabilitation may occur. An elevated cognition state can occur while the patient is sleeping (REM sleep) or while awake (in an intense cognitive challenge state).
(121) The method may control the stimulation based on reading of physiological state detectors, like a motion detector, a brain activity detector such as an electroencephalograph (EEG) detector, a heart rate detector such as electrocardiogram (ECG) and others. The method may adjust stimulation to occur at specific times based on the physiological detectors thereby producing the best cognitive effect. Furthermore, the method may adjust in real time the stimulation intensity or frequency to reflect the physiological detector reading representing the patient's physiological state.
(122) A special physiological state of therapeutic interest is sleep where the therapy can be administered to the patient with minimal discomfort. During sleep several distinguishable cognitive states like REM sleep or slow wave sleep (SWS) affect specific brain areas. A method administrating stimulation in conjunction with these states may result in cognitive rehabilitation. The described method can use noninvasive VNS or transcutaneous VNS (tVNS) simplify therapy administration and allow its use for the general population. More specifically, it allows for treatment of patients in moderate condition (which preclude them from invasive solutions) or those which cannot undergo invasive surgery. tVNS can be applied to two main locations, the carotid branch and the auricular branch of the vagus nerve. The auricular branch (ABVN) is better suited for prolong administration of therapeutic device described in this method.
DETAILED DESCRIPTION OF FIGURES
(123) The following description should be read in conjunction with the Description of the Invention that appears above.
(124) The numerous innovative teachings of the present application will be described with particular reference to presently preferred embodiments (by way of example, and not of limitation). The present application describes several inventions, and none of the statements below should be taken as limiting the claims generally. Where block diagrams have been used to illustrate the invention, it should be recognized that the physical location where described functions are performed are not necessarily represented by the blocks. Part of a function may be performed in one location while another part of the same function is performed at a distinct location. Multiple functions may be performed at the same location.
(125)
(126)
(127)
(128)
(129)
(130)
(131)
(132) With reference to
(133) The patient (101) receives different stimulations (114) from different stimulators (104). The stimulators (104) can be one or more from the list of: electrical stimulator, mechanical (pressure or vibration) stimulator, cognitive stimulator (an interactive computer, tablet or smartphone), thermal stimulator (heat), audio stimulation, and more. A single stimulator of the same kind or more than one of the same kind may be applied.
(134) A control unit (103) orchestrates the stimulation by defining timing, intensity and pattern of each stimulator (104) by direct communication (113) with each stimulator. Control unit (103) may be integrated with other parts of the system or stand alone. The communication (113 and 112) of the control unit may be wired to the system's stimulators and detectors or this could be affected in a wireless configuration.
(135) The detectors (102) may include one or more detectors from the list of: brain activity detector like EEG, heart rate detector like ECG, breathing detector, motion detector, sleep detector, eye tracking detector, cognitive detector like tablet interacting with the patient, etc. Each specific detector or sensor (102) will sequentially measure attributes of the specific measured parameters and report (112) them directly to the control unit (103) to decide on the appropriate stimulation (114) by the dedicated stimulator (104).
(136) The special close loop sensing and stimulation method illustrated in
(137) It should be noted that a combination of the stimulation control mechanisms can be used involving more than one sensor or detector enabling stimulation control based on a combination of body conditions, for example elevated heart rate (measured with ECG) while walking (measured with an activity sensor) or REM sleep (measured by a sleep detector combined with an EEG sensor).
(138)
(139)
(140)
(141)
(142)
(143)
(144)
(145)
(146)
(147)
(148)
(149)
(150) It is to be understood that the embodiments of the invention herein described are merely illustrative of the application of the principles of the invention. While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications and other applications of the invention may be made.